KATHERINE FOSS: Open Payments
NPI 1700582962 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,428 in 67 payments from 25 companies in 2025. Trend: 2023 $1,818 · 2024 $2,290 · 2025 $1,428
Food & beverage: $1,428
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $275 |
| Merck Sharp & Dohme LLC | 9 | $216 |
| Novartis Pharmaceuticals Corporation | 8 | $202 |
| Daiichi Sankyo Inc. | 6 | $138 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Eisai Inc. | 3 | $58 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| PFIZER INC. | 2 | $50 |
| Genentech USA, Inc. | 2 | $46 |
| Geron Corporation | 2 | $41 |
Products named: LYNPARZA, RINVOQ, Enhertu, KEYTRUDA, SCEMBLIX, Fabhalta, Lenvima, KISQALI.
Industry payments across GA — which companies pay providers there.
